✦ LIBER ✦

Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs

✍ Scribed by Regina Treudler; Katja Pohle; Jan Christoph Simon

Publisher: Springer
Year: 2011
Tongue: English
Weight: 68 KB
Volume: 67
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-011-1022-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is radical trachelectomy a safe alternat

Is radical trachelectomy a safe alternative to radical hysterectomy for patients with Stage IA–B carcinoma of the cervix?

✍ Allan Covens; Patricia Shaw; Joan Murphy; Denny DePetrillo; Gordon Lickrish; Ste 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

The prognosis associated with lymph node negative, early stage carcinoma of the cervix is excellent, with 5-year survival rates greater than 90%. Radical trachelectomy in combination with pelvic lymph node dissection (RVT ϩ LPL) has emerged as an alternative to radical hysterectomy (RH) for these p

Tolerance to coxibs in patients with int

Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature

✍ Tobias Bernd Weberschock; Sylke-Monina Müller; Sandra Boehncke; Wolf-Henning Boe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 323 KB

Is it safe to perform laparoscopic ventr

Is it safe to perform laparoscopic ventral hernia repair with mesh in elderly patients?

✍ Y. K. Lee; A. Iqbal; M. Vitamvas; C. McBride; J. Thompson; D. Oleynikov 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 215 KB

Replacement of conventional doxorubicin

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors

✍ Christian Johannes Schmitt; Sascha Dietrich; Antony Dick Ho; Mathias Witzens-Har 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 172 KB

Tenoxicam, a non-steroid anti-inflammato

Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon

✍ Jean-Pierre Zarski; Marianne Maynard-Muet; Suzanne Chousterman; Maryline Baud; R 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The purpose of this study is to compare a combination of interferon (IFN)-␣ 2 a (Roferon) ؉ Tenoxicam with IFN-␣ 2 a alone in the treatment of chronic hepatitis C. This prospective, randomized double-blind study included 149 patients, all of whom were diagnosed with active chronic hepatitis C but no